Overview

Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02

Status:
Unknown status

Trial end date:
2021-08-30

Target enrollment:

Participant gender:

Summary

This phase III trial is designed to explore a higher radiation dose by using IMRT simultaneous integrated boost technique with or without concurrent chemotherapy for esophageal carcinoma with limited lymph node metastasis.

Phase:

Phase 3

Details

Lead Sponsor:

Chinese Academy of Medical Sciences

Collaborators:

Affiliated Hospital of Hebei University
Anyang Tumor Hospital
Fujian Cancer Hospital
Hebei Medical University Fourth Hospital
Sichuan Cancer Hospital and Research Institute
The First Affiliated Hospital with Nanjing Medical University
Tianjin Medical University Cancer Institute and Hospital

Treatments:

Albumin-Bound Paclitaxel
Paclitaxel